DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”
In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs
DCT Board Approves Concepts For New RFA, New And Recompeting Contracts
Major Changes In NCI Drug screening Tumor Panels Approved
Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal
Ethics Commission Say HHS Should Test Injury Compensation
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”









